Pelliciari, D.H.S., Reis, C.R.A. and Bordini, C.A. (2024) “Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? - a pharmacoeconomic study”, Headache Medicine, 15(3), pp. 170–174. doi:10.48208/HeadacheMed.2024.34.